Literature DB >> 28595557

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease.

Giulia Nesi1, Simona Sestito1, Maria Digiacomo1, Simona Rapposelli1.   

Abstract

Alzheimer Diseases (AD) is a multifactorial pathology characterized by a complex etiology. The hallmarks of AD, such as Aβ deposits in senile plaque and Neurofibrillary Tangles (NFT), are strongly intertwined with Reactive Oxygen Species (ROS) production and oxidative stress (OS), which are considered the common effectors of the cascade of degenerative events. An increasing body of evidence reveals that both mitochondrial abnormalities and metal accumulations synergistically act as major producers of ROS, thus contributing to neuronal toxicity. Consequently, the detrimental role of ROS production together with the neurodegenerative events involved in AD has been widely investigated as new potential therapeutic strategies. This review will concisely summarize the link between OS and the hallmarks of AD, emphasizing on their strong correlation with neurodegenerative events and elucidating the pivotal role of ROS in AD pathology. Furthermore, through this review, we will provide a short account of some of the efforts, challenges and opportunities in developing multitarget drugs by addressing ROS production, metal accumulation and protein depositions. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  AD therapy; Alzheimer diseases; Hybrid scaffold; Multitarget-ligand; Neurodegeneration; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28595557     DOI: 10.2174/1568026617666170607114232

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  21 in total

1.  The 40-Hz White Light-Emitting Diode (LED) Improves the Structure-Function of the Brain Mitochondrial KATP Channel and Respiratory Chain Activities in Amyloid Beta Toxicity.

Authors:  Maryam Nazari; Taha Vajed-Samiei; Nihad Torabi; Javad Fahanik-Babaei; Reza Saghiri; Fariba Khodagholi; Afsaneh Eliassi
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

Review 2.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

3.  Design, synthesis, and evaluation of 8-aminoquinoline-melatonin derivatives as effective multifunctional agents for Alzheimer's disease.

Authors:  Ziwei Chen; Xuefeng Yu; Lei Chen; Lexing Xu; Yu Cai; Shanshan Hou; Miaodan Zheng; Fuhe Liu
Journal:  Ann Transl Med       Date:  2022-03

4.  Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease.

Authors:  Chandra Bhushan Mishra; Shruti Shalini; Siddharth Gusain; Amresh Prakash; Jyoti Kumari; Shikha Kumari; Anita Kumari Yadav; Andrew M Lynn; Manisha Tiwari
Journal:  RSC Adv       Date:  2020-05-05       Impact factor: 3.361

5.  New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.

Authors:  Lorenza Bellusci; Annunziatina Laurino; Martina Sabatini; Simona Sestito; Paola Lenzi; Laura Raimondi; Simona Rapposelli; Francesca Biagioni; Francesco Fornai; Alessandra Salvetti; Leonardo Rossi; Riccardo Zucchi; Grazia Chiellini
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

6.  Memantine prodrug as a new agent for Alzheimer's Disease.

Authors:  Simona Sestito; Simona Daniele; Deborah Pietrobono; Valentina Citi; Lorenza Bellusci; Grazia Chiellini; Vincenzo Calderone; Claudia Martini; Simona Rapposelli
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

7.  The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease.

Authors:  Jung Goo Lee; Young Sup Woo; Sung Woo Park; Dae-Hyun Seog; Mi Kyoung Seo; Won-Myong Bahk
Journal:  Brain Sci       Date:  2019-10-21

8.  α-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2.

Authors:  Bingxu Huang; Juxiong Liu; Shoupeng Fu; Yufei Zhang; Yuhang Li; Dewei He; Xin Ran; Xuan Yan; Jian Du; Tianyu Meng; Xiyu Gao; Dianfeng Liu
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

9.  Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice.

Authors:  Lizhi Chen; Shicheng Xu; Tong Wu; Yijia Shao; Li Luo; Lingqi Zhou; Shanshan Ou; Hai Tang; Wenhua Huang; Kaihua Guo; Jie Xu
Journal:  Aging (Albany NY)       Date:  2019-11-19       Impact factor: 5.682

10.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.